Mum Bryony Thomas, 46, was told her cancerous tumour was borderline inoperable - and that she only had around 12 weeks left to live if doctors could not remove it ...

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

At City of Hope, one of the most advanced treatment organizations in the U.S. and ranked among the nation’s top five cancer ...

High-dose intravenous vitamin C doubles survival in metastatic pancreatic cancer, extending life without added toxicity or ...

Pancreatic ductal adenocarcinoma (PDAC ... enabling greater T cell (as well as chemotherapy) delivery into the tumor. However ...

In most cases, pancreatic cancer does not cause symptoms until the disease is advanced. When this happens, some of the signs ...

November is pancreatic cancer awareness month, dedicated to informing people about the disease and screenings available for ...

Pancreatic cancer, a highly aggressive disease, often diagnosed late, has a low survival rate. Genetic testing provides ...

Pancreatic cancer is expected to be the second deadliest cancer in Portugal by 2035, with more than 2,000 deaths a year.

Ohio State cancer researchers and surgeons are developing and deploying cutting-edge techniques to help patients.

The running group Project Purple is devoted to raising awareness and increasing research for pancreatic cancer.

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...